Autonomize AI, a pioneer in Agentic AI orchestration for healthcare and life sciences, has appointed Scott Brennan as Head of Growth and Ujjwal Rajbhandari as Head of Solutions to its leadership team. These strategic hires, announced on September 12, 2025, aim to accelerate the adoption of accountable, human-centered AI solutions in healthcare, following a $28 million Series A funding round.
Scott Brennan named Head of Growth, bringing 15+ years in healthcare and tech.
Ujjwal Rajbhandari appointed Head of Solutions, with expertise in AI infrastructure.
Autonomize AI raised $28M in Series A from Valtruis, Cigna, and Tau Ventures.
Platform streamlines care management, utilization, and benefits workflows.
Focuses on transparent, defensible AI for healthcare providers and payers.
Leadership additions to drive scalable, accountable AI adoption.
Autonomize AI’s new executives bring extensive experience to support the company’s mission of transforming healthcare operations. “Healthcare is at an inflection point,” said Ganesh Padmanabhan, CEO and Co-Founder of Autonomize AI. “With regulatory pressures increasing and agentic AI advancing at an unprecedented pace, the need for trusted and scalable enterprise solutions has never been greater.” Brennan and Rajbhandari will drive growth and innovation, leveraging the company’s recent $28 million Series A funding from Valtruis, The Cigna Group Ventures, and Tau Ventures.
As Head of Growth, Scott Brennan brings over 15 years of experience in healthcare and technology go-to-market strategies. Previously SVP of Business Development at TurningPoint Healthcare Solutions, he enabled health plans to adopt value-based care models. Brennan also led an early-stage healthcare startup to a successful acquisition after achieving 10x EBITDA growth. “Scott’s unique background at the intersection of healthcare delivery, payer operations, and technology makes him an incredible asset,” said Padmanabhan. His expertise will translate Autonomize AI’s innovations into measurable outcomes for payers, providers, and patients.
Ujjwal Rajbhandari, Head of Solutions, joins with deep expertise in AI infrastructure and cloud strategy from leadership roles at Google and Dell. As co-founder and CTO of a startup, he launched a hybrid cloud GPU-as-a-Service platform, and at Dell, he drove global hybrid cloud transformation initiatives. “Ujjwal combines technical depth with go-to-market execution,” said Padmanabhan. His ability to build scalable platforms will accelerate the integration of AI Agents into enterprise healthcare systems, enhancing workflows like care management and utilization management.
Autonomize AI’s platform deploys pre-trained AI Agents to streamline complex healthcare processes, including care management, claims, and benefits checks. By blending automation with human expertise, it reduces administrative bottlenecks, lowers costs, and improves patient experiences. The platform ensures transparency and data traceability, making it trusted by providers, payers, life sciences, and digital health leaders.
The leadership expansion follows Autonomize AI’s $28 million Series A round, signaling strong investor confidence in its mission to deliver accountable AI solutions. With Brennan and Rajbhandari, the company is well-positioned to scale its platform and meet the growing demand for AI-driven healthcare transformation, addressing regulatory pressures and operational challenges.
Autonomize AI uses specialized AI Agents to simplify healthcare’s most complex processes, transforming them into streamlined, AI-native operations. The platform reduces administrative bottlenecks across utilization management, care management, contracts, claims, and payments, delivering faster decisions, lower costs, and better patient experiences. Trusted by providers, payers, life sciences, and digital health leaders, Autonomize ensures every decision is transparent, defensible, and data-traceable.